Avid bioservices to report financial results for second quarter of fiscal year 2023 after market close on december 6, 2022

Tustin, calif., nov. 29, 2022 (globe newswire) -- avid bioservices, inc. (nasdaq:cdmo), a dedicated biologics contract development and manufacturing organization (cdmo) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the second quarter of fiscal year 2023 on december 6, 2022 after market close and will host a webcast at 1:30 pm pacific time (4:30 pm eastern time). members of avid's senior management will discuss financial results for the second quarter and review recent corporate developments.
CDMO Ratings Summary
CDMO Quant Ranking